- Report
- July 2024
- 120 Pages
Global
From €5312EUR$5,950USD£4,618GBP
- Report
- October 2022
- 270 Pages
Global
From €3348EUR$3,750USD£2,911GBP
- Report
- September 2022
- 232 Pages
Global
From €3124EUR$3,500USD£2,717GBP
- Report
- August 2022
- 222 Pages
Global
From €3124EUR$3,500USD£2,717GBP
- Report
- May 2022
- 190 Pages
Global
From €3124EUR$3,500USD£2,717GBP
- Report
- March 2024
- 221 Pages
Global
From €2187EUR$2,450USD£1,902GBP
- Report
- August 2023
- 250 Pages
Global
From €2223EUR$2,490USD£1,933GBP
- Report
- May 2024
- 170 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- September 2021
- 111 Pages
Global
From €4017EUR$4,500USD£3,493GBP
- Report
- July 2022
- 40 Pages
China
From €2857EUR$3,200USD£2,484GBP
- Report
- May 2024
- 200 Pages
Global
From €3705EUR$4,150USD£3,221GBP
- Report
- October 2023
- 145 Pages
Global
From €2812EUR$3,150USD£2,445GBP
- Report
- October 2023
- 145 Pages
Global
From €2812EUR$3,150USD£2,445GBP
- Report
- August 2024
- 60 Pages
Global
From €1071EUR$1,200USD£931GBP
€1339EUR$1,500USD£1,164GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2678EUR$3,000USD£2,329GBP
€3348EUR$3,750USD£2,911GBP
- Report
- July 2024
- 231 Pages
Global
From €5678EUR$6,360USD£4,937GBP
€7097EUR$7,950USD£6,171GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €5678EUR$6,360USD£4,937GBP
€7097EUR$7,950USD£6,171GBP
- Report
- February 2024
- 30 Pages
United States
€1607EUR$1,800USD£1,397GBP
€2009EUR$2,250USD£1,746GBP
- Report
- November 2023
- 30 Pages
Global
From €2321EUR$2,600USD£2,018GBP
€2901EUR$3,250USD£2,523GBP
- Report
- May 2023
- 450 Pages
Global
From €3571EUR$4,000USD£3,105GBP
€4463EUR$5,000USD£3,881GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more